Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis
2019 · Journal of Controlled Release · 410 citations
https://doi.org/10.1016/j.jconrel.2019.12.005
H
Hongyan Zhu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
144
Papers
6.2K
Citations
42
h-index
92
i10-index
Hongyan Zhu is an academic researcher from Kunming University of Science and Technology. The author has contributed to research in topics: Nanoplatforms for cancer theranostics & Nanoparticle-Based Drug Delivery & RNA Interference and Gene Delivery. The author has an h-index of 42, co-authored 123 publications.
ORCID: 0000-0002-5985-8533Papers by this author
worksEnzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy
2017 · Acta Biomaterialia · 175 citations
https://doi.org/10.1016/j.actbio.2017.02.047
Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment
2020 · Acta Pharmaceutica Sinica B · 103 citations
https://doi.org/10.1016/j.apsb.2020.07.023
Recent advances in hyaluronic acid-based nanomedicines: Preparation and application in cancer therapy
2022 · Carbohydrate Polymers · 98 citations
https://doi.org/10.1016/j.carbpol.2022.119662
Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer
2022 · Journal of Nanobiotechnology · 92 citations
https://doi.org/10.1186/s12951-022-01526-2
Mesoporous silica-coated gold nanostars with drug payload for combined chemo-photothermal cancer therapy
2018 · Journal of drug targeting · 40 citations
https://doi.org/10.1080/1061186x.2018.1499746
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat